BeStock  
股票 › 医疗器械 › CNMD

康美德 CNMD

美股市值排名 #2929医疗器械
$51.50 −$1.33 (-2.52%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $51.50 0.00%
开盘$51.11
昨收$52.83
当日区间$51.11 – $52.39
成交量331.6K
市值$1.53B
市盈率(TTM)21.4
股息率–

CNMD 相关新闻

匹配 ConMed 或代码 CNMD 的头条新闻,按最新排序。

  • A Quick Look at Today's Ratings for ConMed(CNMD.US), With a Forecast Between $45 to $46Market news · 31 Jul 2026 · 直接提及
  • J.P. Morgan Maintains ConMed(CNMD.US) With Hold Rating, Maintains Target Price $40Market news · 13 Jul 2026 · 直接提及
  • Needham Maintains ConMed(CNMD.US) With Hold RatingMarket news · 13 Jul 2026 · 直接提及
  • BofA Securities Maintains ConMed(CNMD.US) With Hold Rating, Cuts Target Price to $40 负面Market news · 18 May 2026 · 直接提及
  • Needham Maintains ConMed(CNMD.US) With Hold Rating, Announces Target Price $35.96Market news · 30 Apr 2026 · 直接提及
  • J.P. Morgan Maintains ConMed(CNMD.US) With Hold Rating, Cuts Target Price to $40 负面Market news · 30 Apr 2026 · 直接提及
  • Piper Sandler Maintains ConMed(CNMD.US) With Hold Rating, Maintains Target Price $39Market news · 30 Apr 2026 · 直接提及
  • Analysts Offer Insights on Healthcare Companies: Conmed (CNMD), Alto Neuroscience, Inc. (ANRO) and Pfizer (PFE)TipRanks · 18 Mar 2026 · 直接提及
  • Wells Fargo Maintains ConMed(CNMD.US) With Hold Rating, Cuts Target Price to $42 负面Market news · 18 Mar 2026 · 直接提及
  • Piper Sandler Downgrades ConMed(CNMD.US) to Hold Rating, Cuts Target Price to $39 负面Market news · 17 Mar 2026 · 直接提及
  • Wells Fargo Maintains ConMed(CNMD.US) With Hold Rating, Raises Target Price to $49 正面Market news · 29 Oct 2026 · 直接提及
  • Needham Maintains ConMed(CNMD.US) With Hold RatingMarket news · 29 Oct 2026 · 直接提及
  • J.P. Morgan Maintains ConMed(CNMD.US) With Hold Rating, Raises Target Price to $50 正面Market news · 29 Oct 2026 · 直接提及
  • Piper Sandler Maintains ConMed(CNMD.US) With Buy Rating, Maintains Target Price $55Market news · 29 Jan 2026 · 直接提及
  • TR | OpenAI - 4o Maintains ConMed(CNMD.US) With Buy Rating, Maintains Target Price $60Market news · 12 Aug 2025 · 直接提及

讨论区

暂无评论——快来第一个聊聊 CNMD。

登录后参与讨论。

Scroll to Top